文献速递儿科与产科急症重症综合管理与镇静镇痛

鼻内氯胺酮用于儿童操作镇静:开放标签多中心临床试验

Intranasal ketamine for procedural sedation in children: An open-label multicenter clinical trial.
PubMed 文献 · Am J Emerg Med · 2023-01-30
一句话结论儿童撕裂伤缝合前给予单剂鼻内氯胺酮6 mg/kg,按预设定义60%达到有效镇静,17%镇静欠佳但操作仍以极小困难完成,无严重不良事件。

本研究为单臂、开放标签多中心临床试验,纳入加拿大两个儿科急诊科2018年4月至2019年12月收治的1至12岁需缝合的撕裂伤患儿30例,给予单剂鼻内氯胺酮6 mg/kg行操作镇静。主要终点为达到有效操作镇静的比例,结果为18/30(60%[95%CI 45,80]);5例(17%)镇静欠佳但操作以极小困难完成;7例(23%)镇静差,其中3例(10%)需追加镇静药物。未报告严重不良事件。作者认为单剂鼻内氯胺酮6 mg/kg可使60%患儿按预设定义成功镇静。

要点

  • 1至12岁儿童撕裂伤缝合,单剂鼻内氯胺酮6 mg/kg,有效镇静18/30(60%[95%CI 45,80])。
  • 5例(17%)镇静欠佳,但操作仍以极小困难完成。
  • 7例(23%)镇静差,其中3例(10%)需追加镇静药物。
  • 未报告严重不良事件。
  • 本试验为单臂开放标签设计,无对照组。

适用人群与场景

  • 加拿大两个儿科急诊科收治的1至12岁需缝合的撕裂伤患儿,采用便利抽样连续纳入30例。

处置流程与药物剂量

  • 单剂鼻内氯胺酮6 mg/kg用于撕裂伤缝合的操作镇静。
  • 3例(10%)镇静差患儿需追加镇静药物。

研究设计与关键结果

  • 单臂、开放标签多中心临床试验,两个儿科急诊科,2018年4月至2019年12月纳入30例1至12岁撕裂伤缝合患儿,给予单剂鼻内氯胺酮6 mg/kg。
  • 撕裂伤以面部为主21例(70%),长度大于2 cm者20例(67%)。
  • 主要终点有效操作镇静18/30(60%[95%CI 45,80])。
  • 镇静欠佳5例(17%),操作以极小困难完成;镇静差7例(23%),其中3例(10%)需追加镇静药物。
  • 未报告严重不良事件。

证据类型、等级与局限

  • 证据类型:单臂、开放标签多中心临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,单剂鼻内氯胺酮6 mg/kg用于儿童撕裂伤缝合可使60%患儿按预设定义成功镇静,另17%镇静欠佳但操作仍以极小困难完成。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: There are limited options for pain and distress management in children undergoing minor procedures, without the burden of an intravenous line insertion. Prior to this study, we conducted a dose-escalation study and identified 6 mg/kg as a potentially optimal initial dose of intranasal ketamine.

OBJECTIVE: To assess the efficacy and safety of intranasal ketamine at a dose of 6 mg/kg for procedural sedation to repair lacerations with sutures in children in the emergency department.

METHODS: We conducted a single-arm, open-label multicenter clinical trial for intranasal ketamine for laceration repair with sutures in children aged 1 to 12 years. A convenience sample of 30 patients received 6 mg/kg of intranasal ketamine for their procedural sedation. The primary outcome was the proportion (95% CI) of patients who achieved an effective procedural sedation.

RESULTS: We recruited 30 patients from April 2018 to December 2019 in two pediatric emergency departments in Canada. Lacerations repaired were mostly facial in 21(70%) patients and longer than 2 cm in 20 (67%) patients. Sedation was effective in 18/30 (60% [95% CI 45, 80]) children and was suboptimal in 5 (17%) patients but procedure was completed in them with minimal difficulties. Sedation was poor in the remaining 7 (23%) patients, with 3 (10%) of them required additional sedative agents. No serious adverse events were reported.

CONCLUSIONS: Using a single dose of 6 mg/kg of intranasal Ketamine for laceration repair led to successful sedation in 60% of patients according to our a priori definition. An additional 17% of patients were considered suboptimal, but their procedure was still completed with minimal difficulty.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT03053947).

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Rached-d'Astous S, Finkelstein Y, Bailey B, et al. Intranasal ketamine for procedural sedation in children: An open-label multicenter clinical trial. Am J Emerg Med. 2023. PMID: 36774905. doi:10.1016/j.ajem.2023.01.046

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。